Cita APA

Gaibar Alonso, M., Novillo, A., Romero, A., Fernandez, A., Malón, D., Antón, B., & Moreno, A. (2023). HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment.

Citación estilo Chicago

Gaibar Alonso, María, Apolonia Novillo, Alicia Romero, Ana Fernandez, Diego Malón, Beatriz Antón, y Amalia Moreno. HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship With Response to Neoadjuvant Anti-HER2 Treatment. 2023.

Cita MLA

Gaibar Alonso, María, et al. HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship With Response to Neoadjuvant Anti-HER2 Treatment. 2023.